Identifier to cite or link to this item:

https://hdl.handle.net/20.500.13003/16726

Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study

Date of defense

Publication date

2011-01

Document type

research article

Citation

Morales R., Cuadrado A., Noguera J. F., Dolz C., Vilella A., Riera J., et al. Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study. Rev Esp Enferm Dig. 2011 Jan;103(1):5-12.

Volume Title

Research Projects

Organizational Units

Abstract

Objective: analysis and evaluation of a multidisciplinary approach, postoperative results and survival of a group of patients with resected pancreatic cancer after a multimodal therapy. Design: descriptive, prospective and observational study. Patients: between January 2004 and December 2004, 124 patients with pancreatic cancer were evaluated. In 30 patients pancreatic resection was performed, and they are the object of this study. Results of preoperative evaluation, postoperative morbidity and mortality, and long term survival were studied. Results: diagnostic evaluation was completed in ambulatory basis in 20% of the patients. In 63% of cases, admission was done in the same day of surgery. In 3 patients (9%), tumor resection was not achieved, therefore, concordance between radiological and surgical resectability rate was 91%. Resectability rate was 24.1%. Surgical Mortality was 3.3%, with a global morbidity rate of 56.6%. Survival at one, two, three and, four years was 76.2%, 56.3%, 43%, y 27.3% respectively. Conclusions: technological development and coordination of efforts in multidisciplinary teams offer an accurate evaluation of tumor involvement, and may reduce the number of laparotomies without tumor resection. The application of a systematic and generalized multimodal treatment in pancreatic cancer is progressively showing a tendency of progressive increase in resectability and survival rates in pancreatic cancer.

Description

Publisher version

Research data

Referenced by

It is version of

It is versioned by

Keywords

Pancreatic cancer Multidisciplinary Multimodal Therapy

MeSH

Humans
Adult
Pancreatic Neoplasms
Aged
Aged, 80 and over
Male
Chemotherapy, Adjuvant
Pancreaticoduodenectomy
Stents
Prospective Studies
Hepatectomy
Middle Aged
Antineoplastic Combined Chemotherapy Protocols
Oxaliplatin
Organoplatinum Compounds
Deoxycytidine
Carcinoma
Pancreatectomy
Neoadjuvant Therapy
Kaplan-Meier Estimate
Survival Rate
Colectomy
Female
Patient Care Team
Liver Neoplasms
Cholangiopancreatography, Endoscopic Retrograde
Carcinoma, Pancreatic Ductal
Combined Modality Therapy
Diagnostic Imaging
Aged, 80 and over

DeCS

Adulto
Colectomía
Neoplasias Pancreáticas
Pancreaticoduodenectomía
Carcinoma Ductal Pancreático
Femenino
Neoplasias Hepáticas
Stents
Masculino
Carcinoma
Hepatectomía
Persona de Mediana Edad
Compuestos Organoplatinos
Estudios Prospectivos
Protocolos de Quimioterapia Combinada Antineoplásica
Desoxicitidina
Estimación de Kaplan-Meier
Quimioterapia Adyuvante
Pancreatectomía
Tasa de Supervivencia
Terapia Combinada
Terapia Neoadyuvante
Colangiopancreatografia Retrógrada Endoscópica
Diagnóstico por Imagen
Grupo de Atención al Paciente
Humanos
Anciano
Anciano de 80 o más Años
Oxaliplatino

This item appears in following Docusalut collections